你即將離開本站

並前往https://www.yalemedicine.org/specialists/guoping_cai

Guoping Cai > Specialists > Yale Medicine

Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. Pirazzoli V, Nebhan C, Song X, ...

確定！ 回上一頁

查詢 「mTORC1」的人也找了：

  1. mtorc1中文
    2.
  2. mTORC1
    3.
  3. Active site inhibitors of mtor target rapamycin resistant outputs of mtorc1 and mtorc2
    4.
  4. mTORC1/mTORC2
    5.
  5. ULK1
    6.
  6. mTOR phosphorylation
    7.
  7. 4EBP1
    8.
  8. PI3K
    9.